Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980016/S966

Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I

Medtronic Cardiac Rhythm Disease Management · Decision date Oct 5, 2026

MEDTECHLEDGER EXPLANATIONP980016/S966

What did the FDA decide?

The FDA record for P980016/S966 is a 30-day notice for a process change involving the manufacturer, sterilizer, packager or supplier, with the reported purpose 'to qualify new manufacturing equipment.' The change therefore concerns manufacturing equipment rather than a clinical or labeling element. The record does not identify the specific equipment, where the work is performed, or what technical change the qualification involves.

S966 is a supplement to PMA P980016, which the record ties to Cobalt MRI ICD and Cobalt XT MRI ICD systems and Crome MRI ICD devices, under product code LWS for non-CRT implantable cardioverter defibrillators, filed by Medtronic Cardiac Rhythm Disease Management. The decision date is 2026-10-05 and the decision is 'OK30.' The stated purpose is the applicant's reported basis for the notice, not independent evidence of safety or clinical effectiveness, and this supplement does not constitute approval of the entire system.

FDA approval order statement

to qualify new manufacturing equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980016/S966
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
OK30
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980016 · Original PMA

    VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS

  2. P980016/S966 received

    Application receipt date recorded by FDA.

  3. P980016/S965 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  4. P980016/S966 · FDA decision

    30-Day Notice

  5. P980016/S967 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  6. P980016/S964 · Related supplement

    Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I

Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980016

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records